Gagnon Securities’s GeneDx Holdings Warrant WGSWW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-37,007
Closed -$1.11K 104
2023
Q3
$1.11K Sell
37,007
-10,518
-22% -$292 ﹤0.01% 97
2023
Q2
$489 Sell
47,525
-161
-0.3% -$3 ﹤0.01% 97
2023
Q1
$882 Sell
47,686
-863
-2% -$21 ﹤0.01% 112
2022
Q4
$922 Sell
48,549
-615,329
-93% -$63.5K ﹤0.01% 105
2022
Q3
$151K Sell
663,878
-1,844
-0.3% -$518 0.03% 96
2022
Q2
$216K Buy
665,722
+5,082
+0.8% +$2.07K 0.05% 91
2022
Q1
$456K Buy
660,640
+298,428
+82% +$206K 0.07% 76
2021
Q4
$355K Buy
362,212
+116,239
+47% +$229K 0.05% 85
2021
Q3
$521K Buy
245,973
+218,989
+812% +$720K 0.08% 75
2021
Q2
$124K Buy
+26,984
New +$116K 0.02% 109

Other funds holding WGSWW

Gagnon Securities's WGSWW Position: Q4 2023 in Review

Gagnon Securities sold out of GeneDx Holdings Warrant (WGSWW) in Q4 2023, closing a stake of 37,007 shares — an estimated $1.11K sold.

Gagnon Securities first reported a position in WGSWW in Q2 2021 and held it in 10 quarters. The position peaked at $521K in Q3 2021. 21 funds tracked by Wall St. Rank hold WGSWW as of Q4 2023.

  • Gagnon Securities reported no remaining GeneDx Holdings Warrant position as of Q4 2023 after selling out during the quarter.
  • Gagnon Securities sold 37,007 GeneDx Holdings Warrant shares in Q4 2023, an estimated $1.11K.
  • Gagnon Securities first reported a position in GeneDx Holdings Warrant in Q2 2021 and held it in 10 quarters.
  • Gagnon Securities's GeneDx Holdings Warrant position peaked at $521K in Q3 2021.
  • 21 funds tracked by Wall St. Rank held GeneDx Holdings Warrant as of Q4 2023.

Based on Gagnon Securities's 13F filing for Q4 2023, filed 14 Feb 2024.